National Healthcare Properties, Inc. current report, 26 March 2025

Business Context and Reporting Period

Company: National Healthcare Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2025
Reporting Period: Valuation as of December 31, 2024
Event: Determination of Estimated Per-Share Net Asset Value (NAV) by the Board of Directors.

Key Financial Metrics

Estimated Per-Share NAV: $32.15 (Approved by Board)
NAV Range (Kroll): $32.15 (Low) to $36.96 (High); Midpoint $34.56
Common Shares Outstanding: 28,296,439 (as of Dec 31, 2024)
Real Estate Assets (Final): $77.46 per share
Fair Value of Debt: $(39.25) per share
Preferred Stock Liquidation Values: $(3.60) per share (Series A) and $(3.21) per share (Series B)
Other Assets: $3.43 per share (includes cash, restricted cash, prepaid expenses)
Derivative Assets: $0.68 per share

Material Changes vs. Prior Period

  • NAV Decline: The final Estimated Per-Share NAV of $32.15 represents a significant decrease from the December 31, 2023, final NAV of $52.00.
  • Real Estate Valuation: The per-share value of Real Estate Assets decreased from $96.84 in 2023 to $77.46 in 2024.
  • Share Count: Outstanding shares increased by approximately 1% compared to the prior year (retroactively adjusted for the September 2024 four-for-one reverse stock split).
  • Debt and Liabilities: Fair value of debt per share decreased slightly from $(41.04) to $(39.25), reflecting debt paydowns.
  • Methodology Shifts: Kroll changed the valuation approach for 15 properties between 2023 and 2024, moving some from Direct Capitalization to Discounted Cash Flow (and vice versa) based on cash flow stabilization status.

Guidance, Outlook, and Management Commentary

Board Determination: The Board selected the low end of the Kroll valuation range ($32.15), which was $2.41 below the midpoint ($34.56).

Key Considerations:

  • Decrease in fair values of same-store properties.
  • Impact of the January 2024 stock dividend and the September 2024 four-for-one reverse stock split.
  • Internalization of management functions completed in September 2024 and associated termination fees.
  • Properties in the disposition pipeline under contract or letter of intent.
  • Market uncertainties including political/economic conditions for 2025, occupancy recovery rates for Senior Housing Operating Properties (SHOP), and market rents for Outpatient Medical Facilities (OMF).
  • Heightened interest rate environment impacting future liquidity and cash flows.

Dividend Policy: The Company does not intend to declare further stock dividends. Future stock dividends would dilute the per-share NAV, though total shareholder value would remain proportionate.

Risks and Limitations: The filing explicitly states that the Estimated Per-Share NAV does not represent the price at which shares would trade on an exchange, the liquidation value to a stockholder, or the enterprise value. It does not reflect a liquidity discount or costs associated with asset sales.

Investor Verification Checklist

  • Verify the specific impact of the "decrease in fair values of same-store properties" cited by the Board.
  • Review the status of properties in the disposition pipeline and the likelihood of closing those transactions.
  • Confirm the details of the internalization of management functions and the total costs incurred.
  • Assess the sensitivity of the NAV to changes in capitalization rates (7.07% - 7.57%) and discount rates (8.18% - 9.19%).
  • Understand that the $32.15 NAV is a non-trading estimate and does not guarantee a resale price for shareholders.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.